Embryonal Tumor with Multilayered Rosettes

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas [Phase 1, Phase 2]

  Clinical trial update reports ongoing Phase 1/Phase 2 testing of eflornithine (DFMO) with AMXT 1501 for neuroblastoma, CNS tumors, and sarco…

• CLINICAL_TRIALS research · 2026-03-10
  Clinical Trial Update: Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) [Phase 1]

  This clinical trial update describes an ongoing Phase 1 study evaluating adoptive cellular therapy immunotherapy for several pediatric malig…

• CLINICAL_TRIALS research · 2026-02-27
  Clinical Trial Update: Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation [EARLY_Phase 1]

  This is a pediatric early-phase 1 trial update evaluating intrathecal topotecan with maintenance chemotherapy for high-risk embryonal centra…

• CLINICAL_TRIALS research · 2026-01-27
  Clinical Trial Update: GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults [Phase 1]

  Stanford is conducting a Phase 1 study of GPC2-CAR T cell therapy for relapsed or refractory medulloblastoma and related CNS embryonal tumor…

• CLINICAL_TRIALS research · 2025-06-04
  Clinical Trial Update: ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes

  This entry describes an international registry and research platform for children with Embryonal Tumor With Multilayered Rosettes (ETMR), cu…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.